4
Changes in Ownership
CYTOKINETICS INC Filed Acc 0001127602-25-016865
EVP, Chief Commercial Officer sold 8,659 shares at $32.04 ($277,434)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Callos Andrew · EVP, Chief Commercial Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-06-05 | Sale : show line 1 in the form 10b5-1 | −8,659 | $32.04 | $277,434 | 52,028 | D |
| Open-market sales · 8,659 sh · avg $32.04 · $277,434 | ||||||
Loading xslF345X05/form4.xml…